Severe side effects in patients with B-cell chronic lymphocytic leukemia (CLL) and lymphocytosis treated with the monoclonal anti-CD20 antibody rituximab.

被引：0
|
作者：
Winkler, U [1 ]
Jensen, M [1 ]
Manzke, O [1 ]
Tesch, H [1 ]
Bohlen, H [1 ]
Diehl, V [1 ]
Engert, A [1 ]
机构：
[1] Univ Cologne, Dept Internal Med 1, Cologne, Germany
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4228
引用
收藏
页码：285B / 285B
页数：1
相关论文
共 50 条
  • [31] Ofatumumab: A New CD20 Monoclonal Antibody Therapy for B-Cell Chronic Lymphocytic Leukemia
    O'Brien, Susan
    Osterborg, Anders
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (05): : 361 - 368
  • [32] Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an Anti-CD20 monoclonal antibody (Rituximab, IDEC-C2B8)
    Winkler, U
    Jensen, M
    Manzke, O
    Schulz, H
    Diehl, V
    Engert, A
    BLOOD, 1999, 94 (07) : 2217 - 2224
  • [33] Anti-CD20 monoclonal antibody dependent phagocytosis of chronic lymphocytic leukemia cells by autologous macrophages
    Zent, Clive
    Church, Amy
    VanDerMeid, Karl
    Baig, Nisar
    Baran, Andrea
    Witzig, Thomas
    Nowakowski, Grzegorz
    LEUKEMIA & LYMPHOMA, 2015, 56 : 166 - 166
  • [34] Ofatumumab: a novel, fully human anti-CD20 monoclonal antibody for the treatment of chronic lymphocytic leukemia
    Barth, Matthew J.
    Czuczman, Myron S.
    FUTURE ONCOLOGY, 2013, 9 (12) : 1829 - 1839
  • [35] Monoclonal B-cell lymphocytosis (MBL): A bone marrow study of an indolent form of chronic lymphocytic leukemia (CLL)
    Herrick, J. L.
    Shanafelt, T. D.
    Kay, N. E.
    VanDyke, D. L.
    Morice, W. G.
    Hanson, C. A.
    LABORATORY INVESTIGATION, 2008, 88 : 256A - 256A
  • [36] Association of Polygenic Risk Scores with the Risk of Chronic Lymphocytic Leukemia (CLL) and Monoclonal B-Cell Lymphocytosis (MBL)
    Kleinstern, Geffen
    Camp, Nicola
    Goldin, Lynn
    Call, Timothy G.
    Kay, Neil E.
    BriceWeinberg, J.
    Vachon, Celine M.
    Hanson, Curt
    Cerhan, James R.
    Caporaso, Neil E.
    Slager, Susan L.
    GENETIC EPIDEMIOLOGY, 2017, 41 (07) : 681 - 681
  • [37] Monoclonal B-cell lymphocytosis (MBL): A bone marrow study of an indolent form of chronic lymphocytic leukemia (CLL)
    Herrick, J. L.
    Shanafelt, T. D.
    Kay, N. E.
    VanDyke, D. L.
    Morice, W. G.
    Hanson, C. A.
    MODERN PATHOLOGY, 2008, 21 : 256A - 256A
  • [38] Genetic variants associated with progression from monoclonal B-cell lymphocytosis (MBL) to chronic lymphocytic leukemia (CLL)
    Mwangi, Raphael
    Kleinstern, Geffen
    Achenbach, Sara J.
    Robinson, Dennis
    Norman, Aaron D.
    Rabe, Kari G.
    Olson, Janet E.
    Kay, Neil E.
    Waller, Rosalie G.
    Boddicker, Nicholas J.
    Cerhan, James R.
    Braggio, Esteban
    Parikh, Sameer A.
    Hanson, Curtis A.
    Vachon, Celine M.
    Shanafelt, Tait
    Slager, Susan L.
    CANCER RESEARCH, 2023, 83 (07)
  • [39] Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia
    Bauer, Kathrin
    Rancea, Michaela
    Roloff, Verena
    Elter, Thomas
    Hallek, Michael
    Engert, Andreas
    Skoetz, Nicole
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (11):
  • [40] A Case of Immunotactoid Glomerulopathy (ITG) Associated with Monoclonal B-Cell Lymphocytosis (MBL) with Chronic Lymphocytic Leukemia (CLL) Phenotype Treated with Obinutuzumab
    Aleksidze, Nino
    Stokes, Michael B.
    Skarbnik, Alan P.
    BLOOD, 2017, 130
12345